Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_assertion type Assertion NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_head.
- NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_assertion wasGeneratedBy ECO_0000203 NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_provenance.
- NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_assertion wasDerivedFrom befree-20140225 NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_provenance.
- NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_assertion SIO_000772 16126332 NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_provenance.
- NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_assertion evidence source_evidence_literature NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_provenance.
- NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_assertion description "[The Val158Met polymorphism of COMT is associated with the PSA-progression-free rate of EMP-treated patients in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158947.RArYh48zaYgDJTlIcMAoEYXTDBAbqLJUANOh8Nc1r55bc130_provenance.